Abstract

An efficient, safe, and cost-effective synthesis of 3-carboxy-(2R)-[[hydroxy[(tetradecyl)oxy]phosphinyl]oxy]-N,N,N-trimethyl-1-propanaminium hydroxide inner salt (1, CPI975), a carnitine palmitoyltransferase I inhibitor, is described. The reaction of 1-tetradecanol (2) with stoichiometric amounts of PCl3 in THF at −15 to −20 °C furnished 1-tetradecyl phosphorochloridate (3). Treatment of 3 directly with l-carnitine (7) in THF in the presence of 2,4,6-collidine afforded 8, which was oxidized with bromine to afford a crude aqueous solution of 1. Desalting was done using a cheap, stable, and recyclable resin Amberlite XAD-4. The drug substance was purified by recrystallization from a mixture of ethanol and THF. The yield of 1 was 65% with 99.7% purity. Alternatively, instead of desalting with Amberlite XAD-4 resin, 1 can be isolated by an extraction with 1-decanol, followed by precipitation with acetone and recrystallization from ethanol and THF mixture.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.